CD8A and neoplasm: To further examine the role of T cells, the authors depleted CD-4 and CD-8-expressing cells (75 μg anti-CD4/CD8, i.p. every three days, four doses total) and observed accelerated tumor growth; subsequent DFMO and Trimer PTI co-treatment did not significantly reduce tumor growth [30].